Discovery & Development

Discovery & Development Drug Discovery

09/27/2023 | Robert H Cichewicz | 3 min read

Fungal infections and antifungal resistance are a significant problem; here’s one approach to consider

Discovery & Development Drug Discovery

09/21/2023 | Jamie Irvine | 3 min read

Researchers demonstrate that complex data analysis paired with artificial intelligence can predict additional causes of Teratogenicity

Discovery & Development Drug Discovery

09/19/2023 | Rob Coker | 3 min read

Deputy editor Rob Coker recalls his trip to the labs of Caszyme, Vilnius, where he spoke with CEO Monika Paule about the potential of genome editing

Discovery & Development Drug Discovery

09/18/2023 | 3 min read

The more we learn about the complexity of Alzheimer’s, the more we need to change the way we treat it

Discovery & Development Drug Discovery

09/15/2023 | Stephanie Sutton | 2 min read

With new drugs showing promise for Alzheimer’s, is the drug development drought over?

Discovery & Development Drug Discovery

09/14/2023 | 6 min read

Sitting Down With… Sharon L Rogers, AmyriAD CEO, Renowned drug developer, 2023 Power Lister, and Olympic figure skating official

Discovery & Development Clinical Trials

09/07/2023 | Rob Coker | 4 min read

In the second episode of the We Salute You series, we focus on much maligned Hungarian physician Ignaz Semmelweis

Discovery & Development Drug Discovery

09/06/2023 | Stephanie Sutton | 3 min read

Why one company is focusing on camelid-derived antibodies to tackle dengue.

Discovery & Development Drug Discovery

08/31/2023 | Jamie Irvine | 2 min read

Studying the link between Alzheimer’s risk, estrogen levels, and menopausal status in women

Discovery & Development Drug Discovery

08/30/2023 | Jamie Irvine | 2 min read

Perrigo’s Opill receives FDA approval following unanimous support from advisory committees